FDA Clinical Outcome Assessments and CDISC QRS supplements - Shrishaila Patil - Libros - LAP Lambert Academic Publishing - 9786200454768 - 22 de octubre de 2019
En caso de que portada y título no coincidan, el título será el correcto

FDA Clinical Outcome Assessments and CDISC QRS supplements

Precio
Mex$ 663
sin IVA

Pedido desde almacén remoto

Entrega prevista 28 de sep. - 8 de oct.
Recibe notificaciones sobre nuevos lanzamientos de Shrishaila Patil
Añadir a tu lista de deseos de iMusic

Aún no valorado

CDISC develops SDTM (Study Data Tabulation Model) and ADaM (Analysis Data Model) QRS supplements that provide information on how to structure the data in a standard format for public domain and copyright-approved instruments. An instrument is a series of questions, tasks or assessments used in clinical research to provide a qualitative or quantitative assessment of a clinical concept or task-based observation. This Book is an effort to: - Understand QRS supplements & how it is developed;- Understand how to model ratings and scales other than questionnaires;- Understand ADaM Structure to be used for QRS supplements;- Understand different types of FDA Clinical Outcome Assessment (COA)'s; - Understand how CDISC QRS Supplements assist in structuring COA data so that it is collected and reported in a standardized format.

Medios de comunicación Libros     Paperback Book   (Libro con tapa blanda y lomo encolado)
Publicado 22 de octubre de 2019
ISBN13 9786200454768
Editores LAP Lambert Academic Publishing
Páginas 64
Dimensiones 152 × 229 × 4 mm   ·   104 g
Lengua Inglés